OptimizeRx Corp Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
OptimizeRx Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • OptimizeRx Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.56M, a 141% decline year-over-year.
  • OptimizeRx Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$28.3M, a 73.2% decline year-over-year.
  • OptimizeRx Corp annual Operating Income (Loss) for 2023 was -$26.4M, a 115% decline from 2022.
  • OptimizeRx Corp annual Operating Income (Loss) for 2022 was -$12.3M, a 3504% decline from 2021.
  • OptimizeRx Corp annual Operating Income (Loss) for 2021 was $361K.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$28.3M -$8.56M -$5.01M -141% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$23.3M -$3.75M +$1.1M +22.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 -$24.4M -$5.03M +$2.03M +28.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$26.4M -$10.9M -$10.1M -1165% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 -$16.3M -$3.55M +$204K +5.42% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$16.5M -$4.85M -$940K -24.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 -$15.6M -$7.06M -$3.3M -87.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$12.3M -$864K -$1.49M -239% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 -$10.8M -$3.76M -$3.79M -9937% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$7.01M -$3.91M -$4.25M -1249% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$2.76M -$3.76M -$3.12M -489% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $361K $621K -$735K -54.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $1.1M $38.2K +$215K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $882K $340K +$1.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$514K -$638K +$1.62M +71.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$2.14M $1.36M +$3.67M Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-10
Q3 2020 -$5.81M -$177K +$1.81M +91.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$7.62M -$1.06M -$1.54M -320% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$6.08M -$2.26M -$2.39M -1809% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$3.69M -$2.32M -$2.19M -1748% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$1.5M -$1.99M -$2.21M -990% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $710K $480K +$206K +75.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $503K $132K +$323K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $180K -$125K +$114K +47.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $66.3K $223K +$853K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$787K $274K +$644K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.43M -$191K +$699K +78.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$2.13M -$239K +$129K +35% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$2.26M -$630K -$380K -153% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$1.88M -$371K +$232K +38.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$2.11M -$890K -$529K -146% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 -$1.58M -$368K +$48K +11.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$1.63M -$249K -$337K -385% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$1.29M -$603K -$445K -282% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$848K -$362K -$250K -225% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$597K -$416K -$647K -280% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 $49.1K $87.6K +$382K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$333K -$158K +$42.3K +21.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$376K -$111K +$651K +85.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$1.03M $231K +$810K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$1.84M -$295K -$153K -108% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.68M -$200K -$554K -156% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$1.13M -$762K -$862K -864% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$268K -$580K -$608K -2145% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-09-16
Q3 2013 $341K -$142K -$35.5K -33.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $376K $354K +$430K Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-12
Q1 2013 -$54.2K $99.8K +$401K Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-14
Q4 2012 -$455K $28.4K +$412K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$867K -$106K +$303K +74.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$1.17M -$76.2K +$344K +81.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$1.51M -$301K -$60.5K -25.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$1.45M -$384K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 -$409K +$96K +19% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$420K +$455K +52% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$240K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$505K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-23
Q2 2010 -$875K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.